Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Collegium Pharmaceutical Q1 2024 Adj EPS $1.45 Beats $0.73 Estimate, Sales $144.923M Miss $146.853M Estimate

Author: Benzinga Newsdesk | May 09, 2024 04:46pm
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $0.73 by 98.63 percent. This is a 9.85 percent increase over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $144.923 million which missed the analyst consensus estimate of $146.853 million by 1.31 percent. This is a 0.11 percent increase over sales of $144.767 million the same period last year.

Posted In: COLL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist